IL37 and atherosclerosis: Besides liver injury, IL-37 is also involved in cardiovascular diseases, including atherosclerosis, myocardial infarction (MI) and ischemia/reperfusion injury, because IL-37 reduces inflammatory responses in negative feedback mechanisms.